V CompBrief BY VELARION

Chair of the Board · LEXICON PHARMACEUTICALS, INC. (LXRX)

Chair, Nominating/Governance Committee

Raymond Debbane — LEXICON PHARMACEUTICALS Director Compensation (2025)

Fiscal year 2025 director compensation for Raymond Debbane at LEXICON PHARMACEUTICALS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 16, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Raymond Debbane’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Raymond Debbane and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

LEXICON PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held
In US dollars, as LEXICON PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$85,000$55,516$55,815$0$196,331
FY2022$85,000$16,465$20,387$0$121,852
FY2021$85,000$20,281$25,340$0$130,621

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LEXICON PHARMACEUTICALS, INC. DEF 14A filed March 16, 2026, accession 0001062822-26-000056, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LEXICON PHARMACEUTICALS, INC. filed document, accession 0001062822-26-000056. Every figure is read from that document and cited to the page and table it appears in. Filed March 16, 2026.

Get the LEXICON PHARMACEUTICALS Board Governance Report

$196,331 Raymond Debbane, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of March 16, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

LEXICON PHARMACEUTICALS pays directors a $50,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance (Chair)

The rest of the LEXICON PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Christopher J. SobeckiIndependent Director$161,331
Diane E. SullivanIndependent Director$171,331
Ivan H. CheungIndependent Director$171,331
Judith L. Swain, M.DIndependent Director$173,831
Michael S. Exton, Ph.DDirector—
Philippe J. AmouyalIndependent Director$176,331
Samuel L. Barker, Ph.DIndependent Director$188,831

The full LEXICON PHARMACEUTICALS compensation record

free company brief
LEXICON PHARMACEUTICALS, INC. (LXRX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within LEXICON PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the LEXICON PHARMACEUTICALS proxy · each links to its own free brief

Order LXRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report